Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NADROPARIN vs NALBUPHINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NADROPARIN vs NALBUPHINE: Safety Overview

Metric NADROPARIN NALBUPHINE
Total FAERS Reports 676 702
Deaths Reported 57 78
Death Rate 8.4% 11.1%
Hospitalizations 355 95
Average Patient Age 56.3 yrs 42.1 yrs
% Female Patients 58.5% 63.5%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer N/A Henry Schein, Inc.
Route N/A INTRAMUSCULAR
Marketing Status N/A Discontinued